Comparative Efficacy of Saroglitazar and Pioglitazone in Nonalcoholic Fatty Liver Disease Patients: A Bayesian Network Meta-analysis

Background and Aims: Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome. Two drugs, saroglitazar (S) and pioglitazone (P), are known to have beneficial effects on metabolic syndrome. This Bayesian network meta-analysis (NMA) was conducted to compare the relative efficacy...

Descripció completa

Dades bibliogràfiques

Autors principals:	Binayak Sinha, Samit Ghosal, Debasis Datta
Format:	Artigo
Idioma:	Inglês
Publicat:	Wolters Kluwer Medknow Publications 2024-01-01
Col·lecció:	International Journal of Diabetes and Technology
Matèries:	nonalcoholic fatty liver disease network meta-analysis pioglitazone saroglitazar surface under the cumulative ranking curve
Accés en línia:	https://journals.lww.com/10.4103/ijdt.ijdt_10_24
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!